SCHEMBL10685331

SCHEMBL10685331

CN(C(=O)OCc1ccccc1)c1ccc(C(=O)Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.57
HPGD P15428 3/20 0.57
MAPT P10636 2/20 0.57
LMNA P02545 2/20 0.45
KMT2A Q03164 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
NPC1 O15118 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
GLRA1 P23415 1/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 2/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582815 0.88 ALDH1A1 (0.60) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL27558112 0.86 CHRNB2 (0.56) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL19918329 0.86 ALDH1A1 (0.57) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL12835337 0.85 ALDH1A1 (0.55) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL2615683 0.85 ALDH1A1 (0.47) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL12173013 0.84 ALDH1A1 (0.54) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL27643284 0.83 ALDH1A1 (0.51) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL5700875 0.82 ALDH1A1 (0.52) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL205522 0.82 CHRNB2 (0.51) ALDH1A1HPGDMAPTLMNAKMT2A
SCHEMBL5858822 0.81 ALDH1A1 (0.51) ALDH1A1HPGDMAPTKMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018037120-A1 PRODRUGS ACTIVATED BY REACTIVE OXYGEN SPECIES FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES AND CANCER DANMARKS TEKNISKE UNIVERSITET (DK) 2018-03-01 WO disclosed
WO-2015197872-A1 DERIVATIVES OF OSW-1 AND USE THEREOF FOR THE TREATMENT OF CANCER PIERRE FABRE MEDICAMENT (FR) 2015-12-30 WO disclosed
US-7598092-B2 Methods, devices, systems and computer program products for stochastic, competitive, force-based analyte detection TOONE ERIC 2009-10-06 US disclosed
US-7598092-B2 Methods, devices, systems and computer program products for stochastic, competitive, force-based analyte detection TOONE ERIC 2009-10-06 US disclosed
WO-2008051314-A2 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STOCHASTIC, COMPETITIVE, FORCE-BASED ANALYTE DETECTION DUKE UNIVERSITY (US) 2008-05-02 WO disclosed
US-20080090259-A1 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STOCHASTIC, COMPETITIVE, FORCE-BASED ANALYTE DETECTION TOONE ERIC 2008-04-17 US disclosed
US-20080090259-A1 METHODS, DEVICES, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR STOCHASTIC, COMPETITIVE, FORCE-BASED ANALYTE DETECTION TOONE ERIC 2008-04-17 US disclosed
US-4725687-A ANTITUMOR AGENTS; SIDE EFFECT REDUCTION; POTENCY SOUTHERN RESEARCH INSTITUTE (US) 1988-02-16 US disclosed